Page last updated: 2024-11-05

tolazoline and Carcinoma, Hepatocellular

tolazoline has been researched along with Carcinoma, Hepatocellular in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CATER, DB1

Other Studies

1 other study available for tolazoline and Carcinoma, Hepatocellular

ArticleYear
SOME EFFECTS OF VASODILATOR AND VASOCONSTRICTOR DRUG UPON TUMOUR OXYGEN TENSION.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Amyl Nitrite; Blood Flow Velocity; Blood Pressure Determination; Carbon Dioxide; Carcinoma 256, Walk

1964